• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Mirum Pharmaceuticals, Inc. - common stock (NQ:MIRM)

    99.61 -10.47 (-9.51%)
    Streaming Delayed Price Updated: 12:47 PM EDT, May 7, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,114,656
    Open 110.08
    Bid (Size) 99.40 (100)
    Ask (Size) 99.82 (100)
    Prev. Close 110.08
    Today's Range 98.59 - 112.00
    52wk Range 40.00 - 110.49
    Shares Outstanding 38,297,975
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Penn Capital Unloads 1.13 Million RealReal Shares Following Massive Stock Run-Up ↗
    This online marketplace connects U.S. consumers with consigned luxury goods, spanning apparel, jewelry, art, and home products. 
    Via The Motley Fool
    Topics Artificial Intelligence Regulatory Compliance
    News headline image
    Mirum (MIRM) Q1 2026 Earnings Call Transcript ↗
    Mirum (MIRM) Q1 2026 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings

    Performance

    YTD
    +27.6%
    +27.6%
    1 Month
    +3.5%
    +3.5%
    3 Month
    -4.2%
    -4.2%
    6 Month
    +42.1%
    +42.1%
    1 Year
    +143.0%
    +143.0%

    More News

    Read More
    Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Dips After Q1 Revenue Beat and Guidance Raise, Despite Massive IPR&D Charge ↗
    Via Chartmill
    Mirum Pharmaceuticals (NASDAQ:MIRM) Reports Q4 2025 Revenue Beat and 2026 Outlook ↗
    Via Chartmill
    News headline image
    Mirum Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Mirum Pharmaceuticals Announces Primary Endpoint Met in VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis on May 4, 2026
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Mirum Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 6, 2026
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term ↗
    Via The Motley Fool
    News headline image
    Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Prediction: Buying This Biotech Stock Today Could Set You Up for Life ↗
    Via The Motley Fool
    News headline image
    Mirum (MIRM) Q2 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Mirum Pharma (MIRM) Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Mirum (MIRM) Q1 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings Intellectual Property
    News headline image
    Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position ↗
    Via The Motley Fool
    News headline image
    Mirum Pharmaceuticals Completes Enrollment in Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Additional Rare Cholestatic Liver Diseases
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Hedge Fund Boone Capital Initiated a Stake in HealthEquity. Is the Stock a Buy? ↗
    Via The Motley Fool
    News headline image
    Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Small-Cap Shudder: Russell 2000’s 1.9% Slide Signals Cracks in Economic Resilience
    Via MarketMinute
    Topics Artificial Intelligence Economy Energy
    News headline image
    Mirum Pharmaceuticals Provides AZURE Clinical Program Update for brelovitug in Chronic Hepatitis Delta Virus
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Mirum (MIRM) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2025 Results and Provides Business Update
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    ACM Research’s AI Surge Collides With Export Controls and Chip Spending Cycles ↗
    Via The Motley Fool
    Topics Artificial Intelligence

    Frequently Asked Questions

    Is Mirum Pharmaceuticals, Inc. - common stock publicly traded?
    Yes, Mirum Pharmaceuticals, Inc. - common stock is publicly traded.
    What exchange does Mirum Pharmaceuticals, Inc. - common stock trade on?
    Mirum Pharmaceuticals, Inc. - common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Mirum Pharmaceuticals, Inc. - common stock?
    The ticker symbol for Mirum Pharmaceuticals, Inc. - common stock is MIRM on the Nasdaq Stock Market
    What is the current price of Mirum Pharmaceuticals, Inc. - common stock?
    The current price of Mirum Pharmaceuticals, Inc. - common stock is 99.61
    When was Mirum Pharmaceuticals, Inc. - common stock last traded?
    The last trade of Mirum Pharmaceuticals, Inc. - common stock was at 05/07/26 12:47 PM ET
    What is the market capitalization of Mirum Pharmaceuticals, Inc. - common stock?
    The market capitalization of Mirum Pharmaceuticals, Inc. - common stock is 3.81B
    How many shares of Mirum Pharmaceuticals, Inc. - common stock are outstanding?
    Mirum Pharmaceuticals, Inc. - common stock has 4B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.